While Ozempic may threaten to bankrupt the U.S. healthcare system, the recent approval of the weight loss drug by the Japanese medical authorities will not be the same money-maker for Novo Nordisk. While 42% of American are obese, only 4.5% are obese in Japan. What is so different about Japan? Is it genetics? Is it …Read More